These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 18171452

  • 1. Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD.
    Sandler A, Glesne C, Geller G.
    Child Care Health Dev; 2008 Jan; 34(1):111-20. PubMed ID: 18171452
    [Abstract] [Full Text] [Related]

  • 2. Open-label use of placebos in the treatment of ADHD: a pilot study.
    Sandler AD, Bodfish JW.
    Child Care Health Dev; 2008 Jan; 34(1):104-10. PubMed ID: 18171451
    [Abstract] [Full Text] [Related]

  • 3. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

  • 4. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P, Hsu HY, Chiou SS, Chao MC.
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [Abstract] [Full Text] [Related]

  • 5. Critical influences affecting response to various treatments in young children with ADHD: a case series.
    Heriot SA, Evans IM, Foster TM.
    Child Care Health Dev; 2008 Jan; 34(1):121-33. PubMed ID: 18171453
    [Abstract] [Full Text] [Related]

  • 6. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 9. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ.
    Biol Psychiatry; 2007 Feb 15; 61(4):538-44. PubMed ID: 17276750
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
    Corkum P, Panton R, Ironside S, Macpherson M, Williams T.
    J Pediatr Psychol; 2008 May 15; 33(4):368-79. PubMed ID: 18056144
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S.
    Med Decis Making; 2005 May 15; 25(1):56-70. PubMed ID: 15673582
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Children's self-reports on perceived effects on taking stimulant medication for ADHD.
    Thorell LB, Dahlström K.
    J Atten Disord; 2009 Mar 15; 12(5):460-8. PubMed ID: 18685139
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S.
    Psychiatry Res; 2009 Aug 15; 168(3):234-7. PubMed ID: 19439364
    [Abstract] [Full Text] [Related]

  • 19. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 15; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 20. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.
    Berger I, Dor T, Nevo Y, Goldzweig G.
    J Child Neurol; 2008 Sep 15; 23(9):1036-42. PubMed ID: 18487521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.